Human tumor atlas pilot program
Ended Awarded Last action
- Contract number
- HHSN26100041
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,388,736
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $13,388,735.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,852,726 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $15,241,462 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 28, 2017, under a cost-plus-fixed-fee structure with a ceiling value of $13.4 million for the Human Tumor Atlas Pilot Program, with an ultimate completion date of July 31, 2024.
Place of performance is Frederick, MD. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute and National Institutes of Health, providing biomedical research and facilities support services.
Service Contract Inventory reporting shows declining labor activity over reported fiscal years. FY2022 invoiced $2.9 million across 1.0 FTE and 2,070 contractor hours at a derived government-paid rate of $1,387.18 per hour. FY2023 invoiced $922 thousand across 0.5 FTE and 1,104 contractor hours at $835.28 per hour. FY2024, the most recent reported fiscal year, invoiced $66 thousand across 0.2 FTE and 492 contractor hours at $134.76 per hour. No subcontractors were reported; the prime self-performed all hours.
Quick answers
Who was awarded contract HHSN26100041?
HHSN26100041 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 28, 2017.
How much is contract HHSN26100041 worth?
The government has obligated $13,388,736 on HHSN26100041.
Is contract HHSN26100041 an order under another contract?
Yes. HHSN26100041 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100041 competed?
The extent of competition for HHSN26100041 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award